The developers of three popular health-related mobile apps have agreed to settle allegations that they potentially harmed consumers by making misleading claims about the accuracy of the technologies’ results, the New York Attorney General’s Office announced Thursday.
As part of the agreement, the app developers and the companies agreed “to amend deceptive statements about their apps and modify their privacy policies to better protect consumers, while also making clear that their apps are not medical devices and are not approved by the U.S. Food and Drug Administration,” according to the office of New York Attorney General Eric Schneiderman. The app makers also agreed to pay $30,000 in combined penalties.
